The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anticancer Injection Market Research Report 2024
Synopsis
The global Anticancer Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anticancer Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anticancer Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anticancer Injection include Roche(Genentech), Bayer, Novartis, Pfizer, Amgen, Mabxience, Luoxin Pharmaceutical, Qilu Pharmaceutical and Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anticancer Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Injection.
Report Scope
The Anticancer Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticancer Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticancer Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche(Genentech)
Bayer
Novartis
Pfizer
Amgen
Mabxience
Luoxin Pharmaceutical
Qilu Pharmaceutical
Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
Fuxing Medicine
Yuekang Pharmaceutical
Yuheng Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Changbaishan Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co., Ltd.
Yifan Pharmaceutical
Segment by Type
Docetaxel Injection
Paclitaxel Injection
Bevacizumab Injection
Adalimumab Injection
Rituximab Injection
Others
Segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Testicular Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticancer Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anticancer Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Anticancer Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anticancer Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anticancer Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anticancer Injection include Roche(Genentech), Bayer, Novartis, Pfizer, Amgen, Mabxience, Luoxin Pharmaceutical, Qilu Pharmaceutical and Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anticancer Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Injection.
Report Scope
The Anticancer Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticancer Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticancer Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche(Genentech)
Bayer
Novartis
Pfizer
Amgen
Mabxience
Luoxin Pharmaceutical
Qilu Pharmaceutical
Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
Fuxing Medicine
Yuekang Pharmaceutical
Yuheng Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Changbaishan Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co., Ltd.
Yifan Pharmaceutical
Segment by Type
Docetaxel Injection
Paclitaxel Injection
Bevacizumab Injection
Adalimumab Injection
Rituximab Injection
Others
Segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Testicular Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticancer Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anticancer Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anticancer Injection Market Overview
1.1 Product Overview and Scope of Anticancer Injection
1.2 Anticancer Injection Segment by Type
1.2.1 Global Anticancer Injection Market Value Comparison by Type (2024-2030)
1.2.2 Docetaxel Injection
1.2.3 Paclitaxel Injection
1.2.4 Bevacizumab Injection
1.2.5 Adalimumab Injection
1.2.6 Rituximab Injection
1.2.7 Others
1.3 Anticancer Injection Segment by Application
1.3.1 Global Anticancer Injection Market Value by Application: (2024-2030)
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Lung Cancer
1.3.6 Testicular Cancer
1.3.7 Cervical Cancer
1.3.8 Endometrial Cancer
1.3.9 Prostate Cancer
1.3.10 Bladder Cancer
1.3.11 Others
1.4 Global Anticancer Injection Market Size Estimates and Forecasts
1.4.1 Global Anticancer Injection Revenue 2019-2030
1.4.2 Global Anticancer Injection Sales 2019-2030
1.4.3 Global Anticancer Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anticancer Injection Market Competition by Manufacturers
2.1 Global Anticancer Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anticancer Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anticancer Injection Average Price by Manufacturers (2019-2024)
2.4 Global Anticancer Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anticancer Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anticancer Injection, Product Type & Application
2.7 Anticancer Injection Market Competitive Situation and Trends
2.7.1 Anticancer Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anticancer Injection Players Market Share by Revenue
2.7.3 Global Anticancer Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anticancer Injection Retrospective Market Scenario by Region
3.1 Global Anticancer Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anticancer Injection Global Anticancer Injection Sales by Region: 2019-2030
3.2.1 Global Anticancer Injection Sales by Region: 2019-2024
3.2.2 Global Anticancer Injection Sales by Region: 2025-2030
3.3 Global Anticancer Injection Global Anticancer Injection Revenue by Region: 2019-2030
3.3.1 Global Anticancer Injection Revenue by Region: 2019-2024
3.3.2 Global Anticancer Injection Revenue by Region: 2025-2030
3.4 North America Anticancer Injection Market Facts & Figures by Country
3.4.1 North America Anticancer Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anticancer Injection Sales by Country (2019-2030)
3.4.3 North America Anticancer Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anticancer Injection Market Facts & Figures by Country
3.5.1 Europe Anticancer Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anticancer Injection Sales by Country (2019-2030)
3.5.3 Europe Anticancer Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Anticancer Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Anticancer Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anticancer Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Anticancer Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Anticancer Injection Market Facts & Figures by Country
3.7.1 Latin America Anticancer Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anticancer Injection Sales by Country (2019-2030)
3.7.3 Latin America Anticancer Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anticancer Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Anticancer Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anticancer Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anticancer Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anticancer Injection Sales by Type (2019-2030)
4.1.1 Global Anticancer Injection Sales by Type (2019-2024)
4.1.2 Global Anticancer Injection Sales by Type (2025-2030)
4.1.3 Global Anticancer Injection Sales Market Share by Type (2019-2030)
4.2 Global Anticancer Injection Revenue by Type (2019-2030)
4.2.1 Global Anticancer Injection Revenue by Type (2019-2024)
4.2.2 Global Anticancer Injection Revenue by Type (2025-2030)
4.2.3 Global Anticancer Injection Revenue Market Share by Type (2019-2030)
4.3 Global Anticancer Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anticancer Injection Sales by Application (2019-2030)
5.1.1 Global Anticancer Injection Sales by Application (2019-2024)
5.1.2 Global Anticancer Injection Sales by Application (2025-2030)
5.1.3 Global Anticancer Injection Sales Market Share by Application (2019-2030)
5.2 Global Anticancer Injection Revenue by Application (2019-2030)
5.2.1 Global Anticancer Injection Revenue by Application (2019-2024)
5.2.2 Global Anticancer Injection Revenue by Application (2025-2030)
5.2.3 Global Anticancer Injection Revenue Market Share by Application (2019-2030)
5.3 Global Anticancer Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche(Genentech)
6.1.1 Roche(Genentech) Corporation Information
6.1.2 Roche(Genentech) Description and Business Overview
6.1.3 Roche(Genentech) Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche(Genentech) Anticancer Injection Product Portfolio
6.1.5 Roche(Genentech) Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Anticancer Injection Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Anticancer Injection Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Anticancer Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Anticancer Injection Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Mabxience
6.6.1 Mabxience Corporation Information
6.6.2 Mabxience Description and Business Overview
6.6.3 Mabxience Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mabxience Anticancer Injection Product Portfolio
6.6.5 Mabxience Recent Developments/Updates
6.7 Luoxin Pharmaceutical
6.6.1 Luoxin Pharmaceutical Corporation Information
6.6.2 Luoxin Pharmaceutical Description and Business Overview
6.6.3 Luoxin Pharmaceutical Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Luoxin Pharmaceutical Anticancer Injection Product Portfolio
6.7.5 Luoxin Pharmaceutical Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Pharmaceutical Anticancer Injection Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
6.9.1 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Corporation Information
6.9.2 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Description and Business Overview
6.9.3 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Product Portfolio
6.9.5 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
6.10 Fuxing Medicine
6.10.1 Fuxing Medicine Corporation Information
6.10.2 Fuxing Medicine Description and Business Overview
6.10.3 Fuxing Medicine Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fuxing Medicine Anticancer Injection Product Portfolio
6.10.5 Fuxing Medicine Recent Developments/Updates
6.11 Yuekang Pharmaceutical
6.11.1 Yuekang Pharmaceutical Corporation Information
6.11.2 Yuekang Pharmaceutical Anticancer Injection Description and Business Overview
6.11.3 Yuekang Pharmaceutical Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yuekang Pharmaceutical Anticancer Injection Product Portfolio
6.11.5 Yuekang Pharmaceutical Recent Developments/Updates
6.12 Yuheng Pharmaceutical
6.12.1 Yuheng Pharmaceutical Corporation Information
6.12.2 Yuheng Pharmaceutical Anticancer Injection Description and Business Overview
6.12.3 Yuheng Pharmaceutical Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yuheng Pharmaceutical Anticancer Injection Product Portfolio
6.12.5 Yuheng Pharmaceutical Recent Developments/Updates
6.13 Hengrui Medicine
6.13.1 Hengrui Medicine Corporation Information
6.13.2 Hengrui Medicine Anticancer Injection Description and Business Overview
6.13.3 Hengrui Medicine Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hengrui Medicine Anticancer Injection Product Portfolio
6.13.5 Hengrui Medicine Recent Developments/Updates
6.14 Huiyu Pharmaceutical
6.14.1 Huiyu Pharmaceutical Corporation Information
6.14.2 Huiyu Pharmaceutical Anticancer Injection Description and Business Overview
6.14.3 Huiyu Pharmaceutical Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Huiyu Pharmaceutical Anticancer Injection Product Portfolio
6.14.5 Huiyu Pharmaceutical Recent Developments/Updates
6.15 Changbaishan Pharmaceutical Co., Ltd.
6.15.1 Changbaishan Pharmaceutical Co., Ltd. Corporation Information
6.15.2 Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Description and Business Overview
6.15.3 Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Product Portfolio
6.15.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Innovent Biologics (Suzhou) Co., Ltd.
6.16.1 Innovent Biologics (Suzhou) Co., Ltd. Corporation Information
6.16.2 Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Description and Business Overview
6.16.3 Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Product Portfolio
6.16.5 Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
6.17 Yifan Pharmaceutical
6.17.1 Yifan Pharmaceutical Corporation Information
6.17.2 Yifan Pharmaceutical Anticancer Injection Description and Business Overview
6.17.3 Yifan Pharmaceutical Anticancer Injection Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Yifan Pharmaceutical Anticancer Injection Product Portfolio
6.17.5 Yifan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anticancer Injection Industry Chain Analysis
7.2 Anticancer Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anticancer Injection Production Mode & Process
7.4 Anticancer Injection Sales and Marketing
7.4.1 Anticancer Injection Sales Channels
7.4.2 Anticancer Injection Distributors
7.5 Anticancer Injection Customers
8 Anticancer Injection Market Dynamics
8.1 Anticancer Injection Industry Trends
8.2 Anticancer Injection Market Drivers
8.3 Anticancer Injection Market Challenges
8.4 Anticancer Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anticancer Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anticancer Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anticancer Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anticancer Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anticancer Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anticancer Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anticancer Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anticancer Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anticancer Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anticancer Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anticancer Injection, Product Type & Application
Table 12. Global Key Manufacturers of Anticancer Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anticancer Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anticancer Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anticancer Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Anticancer Injection Sales Market Share by Region (2019-2024)
Table 19. Global Anticancer Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Anticancer Injection Sales Market Share by Region (2025-2030)
Table 21. Global Anticancer Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anticancer Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Anticancer Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anticancer Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Anticancer Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anticancer Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Anticancer Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Anticancer Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anticancer Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anticancer Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anticancer Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anticancer Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anticancer Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anticancer Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anticancer Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anticancer Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anticancer Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anticancer Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anticancer Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anticancer Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anticancer Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anticancer Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anticancer Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anticancer Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anticancer Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anticancer Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anticancer Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anticancer Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anticancer Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anticancer Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Anticancer Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Anticancer Injection Sales Market Share by Type (2019-2024)
Table 53. Global Anticancer Injection Sales Market Share by Type (2025-2030)
Table 54. Global Anticancer Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anticancer Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anticancer Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Anticancer Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Anticancer Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anticancer Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anticancer Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Anticancer Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Anticancer Injection Sales Market Share by Application (2019-2024)
Table 63. Global Anticancer Injection Sales Market Share by Application (2025-2030)
Table 64. Global Anticancer Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anticancer Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anticancer Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Anticancer Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Anticancer Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anticancer Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Roche(Genentech) Corporation Information
Table 71. Roche(Genentech) Description and Business Overview
Table 72. Roche(Genentech) Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche(Genentech) Anticancer Injection Product
Table 74. Roche(Genentech) Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Anticancer Injection Product
Table 79. Bayer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Anticancer Injection Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Anticancer Injection Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Amgen Anticancer Injection Product
Table 94. Amgen Recent Developments/Updates
Table 95. Mabxience Corporation Information
Table 96. Mabxience Description and Business Overview
Table 97. Mabxience Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Mabxience Anticancer Injection Product
Table 99. Mabxience Recent Developments/Updates
Table 100. Luoxin Pharmaceutical Corporation Information
Table 101. Luoxin Pharmaceutical Description and Business Overview
Table 102. Luoxin Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Luoxin Pharmaceutical Anticancer Injection Product
Table 104. Luoxin Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Corporation Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Anticancer Injection Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Corporation Information
Table 111. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Description and Business Overview
Table 112. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Product
Table 114. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
Table 115. Fuxing Medicine Corporation Information
Table 116. Fuxing Medicine Description and Business Overview
Table 117. Fuxing Medicine Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Fuxing Medicine Anticancer Injection Product
Table 119. Fuxing Medicine Recent Developments/Updates
Table 120. Yuekang Pharmaceutical Corporation Information
Table 121. Yuekang Pharmaceutical Description and Business Overview
Table 122. Yuekang Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Yuekang Pharmaceutical Anticancer Injection Product
Table 124. Yuekang Pharmaceutical Recent Developments/Updates
Table 125. Yuheng Pharmaceutical Corporation Information
Table 126. Yuheng Pharmaceutical Description and Business Overview
Table 127. Yuheng Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Yuheng Pharmaceutical Anticancer Injection Product
Table 129. Yuheng Pharmaceutical Recent Developments/Updates
Table 130. Hengrui Medicine Corporation Information
Table 131. Hengrui Medicine Description and Business Overview
Table 132. Hengrui Medicine Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hengrui Medicine Anticancer Injection Product
Table 134. Hengrui Medicine Recent Developments/Updates
Table 135. Huiyu Pharmaceutical Corporation Information
Table 136. Huiyu Pharmaceutical Description and Business Overview
Table 137. Huiyu Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Huiyu Pharmaceutical Anticancer Injection Product
Table 139. Huiyu Pharmaceutical Recent Developments/Updates
Table 140. Changbaishan Pharmaceutical Co., Ltd. Corporation Information
Table 141. Changbaishan Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Product
Table 144. Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Innovent Biologics (Suzhou) Co., Ltd. Corporation Information
Table 146. Innovent Biologics (Suzhou) Co., Ltd. Description and Business Overview
Table 147. Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Product
Table 149. Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
Table 150. Yifan Pharmaceutical Corporation Information
Table 151. Yifan Pharmaceutical Description and Business Overview
Table 152. Yifan Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Yifan Pharmaceutical Anticancer Injection Product
Table 154. Yifan Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anticancer Injection Distributors List
Table 158. Anticancer Injection Customers List
Table 159. Anticancer Injection Market Trends
Table 160. Anticancer Injection Market Drivers
Table 161. Anticancer Injection Market Challenges
Table 162. Anticancer Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anticancer Injection
Figure 2. Global Anticancer Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anticancer Injection Market Share by Type in 2023 & 2030
Figure 4. Docetaxel Injection Product Picture
Figure 5. Paclitaxel Injection Product Picture
Figure 6. Bevacizumab Injection Product Picture
Figure 7. Adalimumab Injection Product Picture
Figure 8. Rituximab Injection Product Picture
Figure 9. Others Product Picture
Figure 10. Global Anticancer Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Anticancer Injection Market Share by Application in 2023 & 2030
Figure 12. Breast Cancer
Figure 13. Stomach Cancer
Figure 14. Ovarian Cancer
Figure 15. Lung Cancer
Figure 16. Testicular Cancer
Figure 17. Cervical Cancer
Figure 18. Endometrial Cancer
Figure 19. Prostate Cancer
Figure 20. Bladder Cancer
Figure 21. Others
Figure 22. Global Anticancer Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 23. Global Anticancer Injection Market Size (2019-2030) & (US$ Million)
Figure 24. Global Anticancer Injection Sales (2019-2030) & (K Units)
Figure 25. Global Anticancer Injection Average Price (US$/Unit) & (2019-2030)
Figure 26. Anticancer Injection Report Years Considered
Figure 27. Anticancer Injection Sales Share by Manufacturers in 2023
Figure 28. Global Anticancer Injection Revenue Share by Manufacturers in 2023
Figure 29. The Global 5 and 10 Largest Anticancer Injection Players: Market Share by Revenue in 2023
Figure 30. Anticancer Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 31. Global Anticancer Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 32. North America Anticancer Injection Sales Market Share by Country (2019-2030)
Figure 33. North America Anticancer Injection Revenue Market Share by Country (2019-2030)
Figure 34. United States Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Canada Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Europe Anticancer Injection Sales Market Share by Country (2019-2030)
Figure 37. Europe Anticancer Injection Revenue Market Share by Country (2019-2030)
Figure 38. Germany Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. France Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. U.K. Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Italy Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Netherlands Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Asia Pacific Anticancer Injection Sales Market Share by Region (2019-2030)
Figure 44. Asia Pacific Anticancer Injection Revenue Market Share by Region (2019-2030)
Figure 45. China Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Japan Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. South Korea Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. India Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. China Taiwan Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Australia Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Latin America Anticancer Injection Sales Market Share by Country (2019-2030)
Figure 53. Latin America Anticancer Injection Revenue Market Share by Country (2019-2030)
Figure 54. Mexico Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Brazil Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Argentina Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Colombia Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Middle East & Africa Anticancer Injection Sales Market Share by Country (2019-2030)
Figure 59. Middle East & Africa Anticancer Injection Revenue Market Share by Country (2019-2030)
Figure 60. Turkey Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Saudi Arabia Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 62. UAE Anticancer Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 63. Global Sales Market Share of Anticancer Injection by Type (2019-2030)
Figure 64. Global Revenue Market Share of Anticancer Injection by Type (2019-2030)
Figure 65. Global Anticancer Injection Price (US$/Unit) by Type (2019-2030)
Figure 66. Global Sales Market Share of Anticancer Injection by Application (2019-2030)
Figure 67. Global Revenue Market Share of Anticancer Injection by Application (2019-2030)
Figure 68. Global Anticancer Injection Price (US$/Unit) by Application (2019-2030)
Figure 69. Anticancer Injection Value Chain
Figure 70. Anticancer Injection Production Process
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Distributors Profiles
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
